❤️ On-Demand SSRI (Dapoxetine-Type) Mechanism Simulator

Taking the Tablet Ahead of Intercourse

Placeholder: dosing window sits roughly one to three hours pre-activity.

• 1–3 h: Recommended window (placeholder pre-dose timing)
• 30–60 mg: Dose range (placeholder strength options)
• On-demand: Use pattern (placeholder, not daily)
• Delayed Tmax: Food effect (placeholder with high-fat meal)

Why timing matters

Placeholder: correct timing aligns peak drug levels with activity.

Placeholder highlight: dosing too early or late reduces benefit.

Rapid Gastrointestinal Absorption

Placeholder: fast absorption rate constant drives quick concentration rise.

• 2.0 /h: Absorption rate (ka) (placeholder model constant)
• ~30–60 min: Onset of action (placeholder clinical estimate)
• ~42%: Bioavailability (placeholder oral fraction)
• >99%: Protein binding (placeholder plasma binding)

Absorption kinetics

Placeholder: concentration rises steeply during first hour post-dose.

Placeholder highlight: rapid rise distinguishes it from chronic SSRIs.

Peak Plasma Concentration (Cmax)

Placeholder: maximum concentration occurs about one to two hours post-dose.

• ~1.0–1.3 h: Tmax (placeholder model output)
• ~310 ng/mL: Cmax (60mg) (placeholder reference value)
• Aligned with Tmax: Effect peak (placeholder timing overlap)
• Roughly linear: Dose linearity (placeholder scaling assumption)

Peak and window overlap

Placeholder: peak timing is designed to overlap intercourse window.

Placeholder highlight: overlap of peak and activity maximizes benefit.

Rapid Elimination Phase

Placeholder: short elimination half-life clears drug within about a day.

• ~1.5 h: Elimination half-life (placeholder terminal t½)
• ~24 h: Near-full clearance (placeholder time estimate)
• Minimal: Accumulation risk (placeholder, no daily dosing)
• CYP3A4/2D6: Metabolism (placeholder hepatic pathway)

Fast washout profile

Placeholder: rapid elimination limits next-day residual effects.

Placeholder highlight: short exposure window reduces side-effect burden.

On-Demand vs. Chronic Daily SSRIs

Placeholder: chronic SSRIs build steady-state levels over weeks, unlike this drug.

• 20–36 h: Chronic SSRI t½ (placeholder typical daily SSRI)
• Not reached: Steady state (placeholder for on-demand use)
• Very low: Discontinuation risk (placeholder vs. chronic use)
• Event-based: Dosing pattern (placeholder vs. once-daily)

Contrasting exposure profiles

Placeholder: flat chronic baseline contrasts with this sharp on-demand spike.

Placeholder highlight: no accumulation avoids chronic steady-state effects.